MARGARET SCHAUER: Open Payments
NPI 1336776657 · WEST ALLIS, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 25 payments from 10 companies in 2025. Trend: 2023 $668 · 2024 $504 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $158 |
| Neurocrine BioSciences, Inc. | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Tris Pharma Inc | 1 | $33 |
| Alkermes, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, INGREZZA, FANAPT, Auvelity, Dyanavel XR, ARISTADA, TRINTELLIX, REXULTI.
Industry payments across WI — which companies pay providers there.
